Van Schil Kristof, Meire Françoise, Karlstetter Marcus, Bauwens Miriam, Verdin Hannah, Coppieters Frauke, Scheiffert Eva, Van Nechel Christian, Langmann Thomas, Deconinck Nicolas, De Baere Elfride
Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Department of Pediatric Ophthalmology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Genet Med. 2015 Apr;17(4):291-9. doi: 10.1038/gim.2014.95. Epub 2014 Aug 14.
The aim of this study was to identify the genetic cause of early-onset autosomal recessive cerebellar ataxia associated with retinal dystrophy in a consanguineous family.
An affected 6-month-old child underwent neurological and ophthalmological examinations. Genetic analyses included homozygosity mapping, copy number analysis, conventional polymerase chain reaction, Sanger sequencing, quantitative polymerase chain reaction, and whole-exome sequencing. Expression analysis of GRID2 was performed by quantitative polymerase chain reaction and immunohistochemistry.
A homozygous deletion of exon 2 of GRID2 (p.Gly30_Glu81del) was identified in the proband. GRID2 encodes an ionotropic glutamate receptor known to be selectively expressed in cerebellar Purkinje cells. Here, we demonstrated GRID2 expression in human adult retina and retinal pigment epithelium. In addition, Grid2 expression was demonstrated in different stages of murine retinal development. GRID2 immunostaining was shown in murine and human retina. Whole-exome sequencing in the proband did not provide arguments for other disease-causing mutations, supporting the idea that the phenotype observed represents a single clinical entity.
We identified GRID2 as an underlying disease gene of early-onset autosomal recessive cerebellar ataxia with retinal dystrophy, expanding the clinical spectrum of GRID2 deletion mutants. We demonstrated for the first time GRID2 expression and localization in human and murine retina, providing evidence for a novel functional role of GRID2 in the retina.
本研究旨在确定一个近亲家庭中与视网膜营养不良相关的早发性常染色体隐性小脑共济失调的遗传病因。
对一名6个月大的患病儿童进行了神经学和眼科检查。基因分析包括纯合性定位、拷贝数分析、常规聚合酶链反应、桑格测序、定量聚合酶链反应和全外显子组测序。通过定量聚合酶链反应和免疫组织化学对GRID2进行表达分析。
在先证者中鉴定出GRID2第2外显子的纯合缺失(p.Gly30_Glu81del)。GRID2编码一种离子型谷氨酸受体,已知其在小脑浦肯野细胞中选择性表达。在此,我们证明了GRID2在成人人类视网膜和视网膜色素上皮中的表达。此外,在小鼠视网膜发育的不同阶段也证明了Grid2的表达。在小鼠和人类视网膜中均显示出GRID2免疫染色。先证者的全外显子组测序未发现其他致病突变的证据,支持所观察到的表型代表单一临床实体的观点。
我们确定GRID2为早发性常染色体隐性小脑共济失调伴视网膜营养不良的潜在致病基因,扩展了GRID2缺失突变体的临床谱。我们首次证明了GRID2在人类和小鼠视网膜中的表达和定位,为GRID2在视网膜中的新功能作用提供了证据。